KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogenomics (NEO) Long-Term Debt Issuances (2019 - 2021)

Neogenomics filings provide 4 years of Long-Term Debt Issuances readings, the most recent being $334.4 million for Q1 2021.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $334.4 million in Q1 2021 year-over-year; TTM through Dec 2021 was $334.4 million, a 71.96% increase, with the full-year FY2021 number at $334.4 million, up 71.96% from a year prior.
  • Long-Term Debt Issuances hit $334.4 million in Q1 2021 for Neogenomics, up from $90000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $334.4 million in Q1 2021 to a low of -$100.0 million in Q3 2019.
  • Median Long-Term Debt Issuances over the past 3 years was $100.0 million (2019), compared with a mean of $105.8 million.
  • The widest YoY moves for Long-Term Debt Issuances: up 100.09% in 2020, down 100.09% in 2020.
  • Neogenomics' Long-Term Debt Issuances stood at $100.0 million in 2019, then plummeted by 99.91% to $90000.0 in 2020, then surged by 371466.67% to $334.4 million in 2021.
  • The last three reported values for Long-Term Debt Issuances were $334.4 million (Q1 2021), $90000.0 (Q3 2020), and $194.4 million (Q2 2020) per Business Quant data.